Showing 1 - 10 of 109
Nipah virus outbreak in India sparks worry in China before Lunar New Year
South China Morning Post, Published on 29/01/2026
» An outbreak of the highly fatal Nipah virus in India's eastern state of West Bengal has sparked widespread attention and public concern in China ahead of the Lunar New Year holiday when millions will travel.
'Blessed': US woman sees second chance in life after pig kidney transplant
AFP, Published on 18/12/2024
» WASHINGTON - Towana Looney donated a kidney to her mother in 1999 only for the remaining one to fail years later due to pregnancy complications.
US approves maternal vaccine to prevent RSV in infants
AFP, Published on 22/08/2023
» WASHINGTON - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
US issues world's first approval of RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.
US approves world's first RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly.
US approves new drug to treat Alzheimer's
AFP, Published on 07/01/2023
» WASHINGTON - The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in the early stages of Alzheimer's disease.
Japan approves simple Alzheimer’s blood test
Bloomberg News, Published on 22/12/2022
» TOKYO: Japan’s health ministry has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the brain-wasting ailment for which a blockbuster therapy is finally on the horizon.
China's Clover says its Covid booster shot candidate lifts antibody against Omicron
Reuters, Published on 27/06/2022
» BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody response against the Omicron coronavirus variant from levels seen after two primary shots.
Over 14% of world has had Lyme disease: study
AFP, Published on 14/06/2022
» PARIS: More than 14% of the world's population has had Lyme disease, the most common tick-borne illness, according to a major review of the available research published on Tuesday.
Pfizer Covid vaccine for under-fives effective with three doses
AFP, Published on 23/05/2022
» WASHINGTON: The Pfizer/BioNTech Covid vaccine is safe and effective for children aged six months to under five years when given in three doses, the companies said in a statement Monday.